Light alcohol consumption may offer limited cardiovascular protection, but risks rise significantly with higher intake. This article examines the evidence linking alcohol use to coronary disease, stroke, PAD, and arrhythmias—highlighting a U-shaped risk curve and reinforcing the need for proven lifestyle interventions over unproven benefits.

Micro- and nanoplastics have been found in human heart tissue, arterial plaques, and blood—with growing evidence linking them to increased cardiovascular disease risk. This article explores how these particles contribute to atherosclerosis, trigger inflammation, disrupt blood and immune cell function, and interfere with clotting mechanisms. A must-read for healthcare professionals seeking to understand the emerging environmental drivers of heart disease.

Explore three standout studies from ACC 2025 that are reshaping heart failure management — from fluid restriction debates to game-changing therapies like dapagliflozin and IV iron. A must-read for clinicians staying ahead in cardiovascular care.

A UK Biobank study of nearly 12,000 people with T2D shows that each additional risk factor controlled—such as BMI, blood pressure, LDL, or HbA1c—lowers heart failure risk by an average of 19%. Those with optimal control of six or more risk factors saw a 67% lower risk and HF-free survival comparable to non-diabetic participants.